Area of interest: healthcare biotech
Type of activity: meeting/debate, labs/training
More info: segreteria@afiscientifica.it, 02.4045361
Biotech drugs are one of the major player of new frontiers in medicine. Whether you talk about macromolecules as antibodies and recombinant proteins or the most innovative cell-based medicinal products, we are facing a big challenge in the health care system. We are moving to a personalized and precision medicine, with drugs more and more tailored for patients, through the research and the development of new biomarkers to select the population of patients that better respond to these new therapies. The aim of the event is to offer a comprehensive overview of biotech drugs, from R&D to production, clinical research and market.
Program
Chairmen:
• C. Caramella – AFI – Università degli Studi
di Pavia
• M.L. Nolli – AFI – NcNBio
• O. Pastoris – Università degli Studi di Pavia
10.00-10.25 The drug discovery process: state of the art and innovation for the discovery of new molecules
• C. Liberati – Axxam
10.25-10.50 Pharmaceutical production towards biotech
• P. Tavecchia – AFI – Recordati
10.50-11.15 Biosimilars: care opportunities
• P. Minghetti – AFI – Università degli Studi di Milano
11.15-11.40 Merck’s experience and tradition in the development of biotech drugs
• L. Colombo – AFI – Merck
11.40-12.05 Alfasigma Biotech Pipeline
• R. De Santis – AFI – Alfasigma
12.05-12.30 Cell therapies: case study of Pavia
Cell Factory
• Patrizia Comoli • Antonia Moretta
Cell Factory, IRCCS Policlinico San Matteo
Pavia
12.30-12.55 General discussion and conclusion
12.55-13.30 Lunch
Organiser: Associazione Farmaceutici dell’Industria, Dipartimento di Biologia e Biotecnologie e Dipartimento di Scienze del Farmaco dell’Università di Pavia